Related Experiment Videos
GC and C3 serum groups in ulcerative colitis
A Archimandritis1, P Koumentakos, M Douvara
1Department of Pathologic Physiology, Laikon General Hospital, University of Athens, Greece.
Human Heredity
|July 1, 1995
Summary
Researchers investigated serum protein systems in ulcerative colitis patients. The study found significant differences in the C3 complement system, with C3*F allele and C3FS phenotype being more common in patients.
Area of Science:
- Immunogenetics
- Gastroenterology
- Biochemistry
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Serum protein polymorphisms may be associated with disease susceptibility or progression.
- The GC and C3 complement systems are involved in immune responses.
Purpose of the Study:
- To investigate the allele frequencies and phenotypes of GC and C3 serum protein systems in patients with ulcerative colitis.
- To compare these frequencies with those in healthy controls.
Main Methods:
- Phenotyping and allele frequency analysis of GC and C3 systems.
- Comparison between 91 ulcerative colitis patients and healthy controls.
Main Results:
- No significant differences were observed in the GC system between patients and controls.
- A significant difference was found in the C3 system.
- The C3*F allele and C3FS phenotype were significantly more frequent in ulcerative colitis patients compared to controls.
Conclusions:
- The C3 complement system, specifically the C3*F allele and C3FS phenotype, may be associated with ulcerative colitis.
- Further research is warranted to elucidate the role of C3 in UC pathogenesis.